Revolution Medicines, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
RVMD Nasdaq 2836 www.revmed.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Revolution Medicines, Inc.

JPM26: Revolution Medicines in spotlight as industry gears up for dealmaking spree - Jan 12th, 2026 5:54 am
AbbVie Inc. (ABBV) Gets Downgraded to Peer Perform From Outperform by Wolfe Research - Jan 10th, 2026 12:57 pm
A Look At Revolution Medicines (RVMD) Valuation After Strong Recent Share Price Momentum - Jan 10th, 2026 11:11 am
Is It Too Late To Consider Revolution Medicines (RVMD) After Its Recent 50% Weekly Surge? - Jan 10th, 2026 3:13 am
Why Revolution Medicines Stock Surged by 11% Today - Jan 9th, 2026 6:16 pm
These Stocks Moved the Most Today: Oklo, Vistra, Opendoor, Intel, GM, Revolution Medicines, Tilray, and More - Jan 9th, 2026 2:43 pm
Sector Update: Health Care Stocks Decline Late Afternoon - Jan 9th, 2026 1:59 pm
Merck in Talks to Buy Revolution Medicines for Around $30 Billion - Jan 9th, 2026 12:58 pm
Merck in Talks to Buy Revolution Medicines Per Financial Times Report - Jan 9th, 2026 10:03 am
Top Midday Stories: December Jobs Data Undershoots Expectations; Meta Signs Nuclear Deals - Jan 9th, 2026 9:49 am
Healthcare dealmakers head to San Francisco hoping for megamergers in 2026 - Jan 9th, 2026 9:19 am
Revolution Medicines Stock Jumps. Takeover Buzz Grows, Another Suitor Emerges. - Jan 9th, 2026 7:54 am
Wall Street Gains Momentum Amid Jobs Report as US Equity Futures Edge Higher Pre-Bell - Jan 9th, 2026 7:07 am
Merck in talks to buy cancer drugmaker Revolution Medicines for up to $32bn - Jan 8th, 2026 5:51 pm
Revolution Medicines stock rises on Merck acquisition talks - Jan 8th, 2026 2:25 pm
Merck in talks to buy biotech Revolution Medicines, FT reports - Jan 8th, 2026 1:58 pm
AbbVie Denies It’s in Talks to Buy Revolution Medicines. Both Stocks Are Falling. - Jan 8th, 2026 7:49 am
RVMD Stock Hits a Record High on Rumored Takeover Interest - Jan 8th, 2026 7:11 am
Revolution Medicines Announces FDA Breakthrough Therapy Designation for Zoldonrasib - Jan 8th, 2026 6:00 am
Revolution Medicines (RVMD) Hits All-Time High on Buyout Buzz; Buyer Denies Talks - Jan 7th, 2026 7:18 pm